14-day Premium Trial Subscription Try For FreeTry Free
FRA:YMP3
Delisted

Symphony Holdings Limited Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
0.0890€
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 6.10€ 80.02€ Wednesday, 17th Aug 2022 YMP3.F stock ended at 0.0890€. During the day the stock fluctuated 0% from a day low at 0.0890€ to a day high of 0.0890€.
90 days 71.43€ 25.28€
52 weeks 0.340€ 25.28€

Historical Symphony Holdings Limited prices

Date Open High Low Close Volume
Aug 23, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Aug 20, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Aug 19, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Aug 18, 2021 0.0905€ 0.0905€ 0.0905€ 0.0905€ 0
Aug 17, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Aug 16, 2021 0.0900€ 0.0900€ 0.0900€ 0.0900€ 0
Aug 13, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Aug 12, 2021 0.0900€ 0.0900€ 0.0900€ 0.0900€ 0
Aug 11, 2021 0.0905€ 0.0905€ 0.0905€ 0.0905€ 0
Aug 10, 2021 0.0900€ 0.0900€ 0.0900€ 0.0900€ 0
Aug 09, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Aug 06, 2021 0.0895€ 0.0895€ 0.0895€ 0.0895€ 0
Aug 05, 2021 0.0895€ 0.0895€ 0.0895€ 0.0895€ 23 250
Aug 04, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 23 250
Aug 03, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 23 250
Aug 02, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 23 250
Jul 30, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 23 250
Jul 29, 2021 0.0870€ 0.0870€ 0.0870€ 0.0870€ 23 250
Jul 28, 2021 0.0870€ 0.0870€ 0.0870€ 0.0870€ 23 250
Jul 27, 2021 0.0865€ 0.0865€ 0.0865€ 0.0865€ 23 250
Jul 26, 2021 0.0880€ 0.0880€ 0.0880€ 0.0880€ 23 250
Jul 23, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 23 250
Jul 22, 2021 0.0890€ 0.0890€ 0.0890€ 0.0890€ 23 250
Jul 21, 2021 0.0910€ 0.0910€ 0.0910€ 0.0910€ 23 250
Jul 20, 2021 0.0900€ 0.0900€ 0.0900€ 0.0900€ 23 250
Click to get the best stock tips daily for free!

About Symphony Holdings Limited

Symphony Holdings Limited Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... YMP3.F Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT